Loader

Pathways

PathWhiz ID Pathway Meta Data

PW144684

Pw144684 View Pathway
drug action

Cephalexin Drug Metabolism Action Pathway

Homo sapiens

PW176326

Pw176326 View Pathway
metabolic

Cephalexin Predicted Metabolism Pathway

Homo sapiens
Metabolites of sildenafil are predicted with biotransformer.

PW176955

Pw176955 View Pathway
drug action

Cephaloglycin Action Pathway

Escherichia coli
Cephaloglycin is a cephalorsporin antibiotic that is no longer commonly used. Cephaloglycin exhibits an anti-bacterial mechanism of action. It works by binding to and inhibiting bacterial penicillin-binding proteins (PBPs). Upon binding to PBPs, ertapenem inhibits bacterial cell wall synthesis by interfering with the lengthening and strengthening of the peptidoglycan portion of the cell wall, thereby inhibiting cell wall synthesis.

PW144801

Pw144801 View Pathway
drug action

Cephaloglycin Drug Metabolism Action Pathway

Homo sapiens

PW121714

Pw121714 View Pathway
disease

Cerebrotendinous Xanthomatosis (CTX)

Mus musculus
Cerebrotendinous Xanthomatosis, also called CTX, is a rare inborn error of metabolism (IEM) which results from a genetic mutation. More specifically, it is the result of a mutated CYP27A1 gene. This said gene is responsible for encoding sterol 27-hydroxylase. The importance of this enzyme if the following, the said enzyme is responsible for the catalysis during the oxidation of several compounds. In particular, the said enzyme interacts with sterol intermediates, and 7-alpha,12-alpha-triol, among others. CTX is rare and can be thought of as an inherited lipid-storage disease. It causes the widespread deposition of two main compounds (cholesterol and cholestanol) throughout essentially every single tissue in the body. Including, the brain and lungs, to the detriment of the affected. Symptoms of CTX are neurological dysfunction, premature atherosclerosis, and cataracts.

PW127263

Pw127263 View Pathway
disease

Cerebrotendinous Xanthomatosis (CTX)

Homo sapiens
Cerebrotendinous Xanthomatosis, also called CTX or 27-Hydroxylase Deficiency, is a rare inborn error of metabolism (IEM) which results from a genetic mutation. More specifically, it is the result of a mutated CYP27A1 gene. This said gene is responsible for encoding sterol 27-hydroxylase. The importance of this enzyme if the following, the said enzyme is responsible for the catalysis during the oxidation of several compounds. In particular, the said enzyme interacts with sterol intermediates, and 7-alpha,12-alpha-triol, among others. CTX is characterized by the accumulation of cholestanol and cholesterol due to the inability to break down the lipids. CTX is rare and can be thought of as an inherited lipid-storage disease. It causes the widespread deposition of two main compounds (cholesterol and cholestanol) throughout essentially every single tissue in the body. Including, the brain and lungs, to the detriment of the affected. Symptoms of CTX are neurological dysfunction (such as dementia), premature atherosclerosis, and cataracts. Other symptoms may include damaged liver cells and body tissues.

PW000196

Pw000196 View Pathway
disease

Cerebrotendinous Xanthomatosis (CTX)

Homo sapiens
Cerebrotendinous Xanthomatosis, also called CTX, is a rare inborn error of metabolism (IEM) which results from a genetic mutation. More specifically, it is the result of a mutated CYP27A1 gene. This said gene is responsible for encoding sterol 27-hydroxylase. The importance of this enzyme if the following, the said enzyme is responsible for the catalysis during the oxidation of several compounds. In particular, the said enzyme interacts with sterol intermediates, and 7-alpha,12-alpha-triol, among others. CTX is rare and can be thought of as an inherited lipid-storage disease. It causes the widespread deposition of two main compounds (cholesterol and cholestanol) throughout essentially every single tissue in the body. Including, the brain and lungs, to the detriment of the affected. Symptoms of CTX are neurological dysfunction, premature atherosclerosis, and cataracts.

PW121939

Pw121939 View Pathway
disease

Cerebrotendinous Xanthomatosis (CTX)

Rattus norvegicus
Cerebrotendinous Xanthomatosis, also called CTX, is a rare inborn error of metabolism (IEM) which results from a genetic mutation. More specifically, it is the result of a mutated CYP27A1 gene. This said gene is responsible for encoding sterol 27-hydroxylase. The importance of this enzyme if the following, the said enzyme is responsible for the catalysis during the oxidation of several compounds. In particular, the said enzyme interacts with sterol intermediates, and 7-alpha,12-alpha-triol, among others. CTX is rare and can be thought of as an inherited lipid-storage disease. It causes the widespread deposition of two main compounds (cholesterol and cholestanol) throughout essentially every single tissue in the body. Including, the brain and lungs, to the detriment of the affected. Symptoms of CTX are neurological dysfunction, premature atherosclerosis, and cataracts.

PW132575

Pw132575 View Pathway
metabolic

Ceritinib Drug Metabolism

Homo sapiens
Ceritinib is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Ceritinib passes through the liver and is then excreted from the body mainly through the kidney.

PW145946

Pw145946 View Pathway
drug action

Ceritinib Drug Metabolism Action Pathway

Homo sapiens